Drug reference
typhoid-paratyphoid a, b vaccine
Killed (Inactivated) bacterial vaccine · Vaccine for typhoid/paratyphoid
Killed (Inactivated) bacterial vaccineVaccine for typhoid/paratyphoid
CDSCO approved
EXCRETION
—
not curated
INTERACTIONS
—
none in our sources
PREGNANCY
—
not curated
Mechanism
The vaccine is a sterile suspension containing S. typhi and S. paratyphi A and B organisms. It acts as an antigen which induces the production of specific antibodies by the recipient.
Indications
Prevention of enteric fever
Dosing
- Adult
- 0.5 ml s.c., 2–3 injections at 2–4 weeks intervals. Booster doses may be given every 2–3 years.
- Pediatric
- 0.5 ml s.c., 2–3 injections at 2–4 weeks intervals. Booster doses may be given every 2–3 years.
Pharmacokinetics
Duration
1 year
Side effects
Common
Local tendernessFeverMalaise (lasting 1–2 days after first dose)
Related guidelines
Other Killed (Inactivated) bacterial vaccine drugs
Ask House about typhoid-paratyphoid a, b vaccine
Continue into a citation-backed clinical answer with the drug context already attached.
Sources: KD Tripathi 7e·Verified: 2026-05-10 · House clinical team